- 0
- 8
What changed
Each line against the same period a year earlier, as the company reported both in its latest filing. The math is under every line.
Latest quarter vs the same quarter a year earlier
10-Q filed 2026-09-11 ↗| Quarter ended | 2025-08-31 | 2026-08-31 | Change |
|---|---|---|---|
| Revenue(19,345 − 14,926) ÷ |14,926| × 100 = +29.6% ($ millions) | $14.9B | $19.3B | +29.6% |
| Operating income(6,728 − 4,277) ÷ |4,277| × 100 = +57.3% ($ millions) | $4.3B | $6.7B | +57.3% |
| Net income(4,760 − 2,927) ÷ |2,927| × 100 = +62.6% ($ millions) | $2.9B | $4.8B | +62.6% |
| Diluted earnings per share(1.56 − 1.01) ÷ |1.01| × 100 = +54.5% ($ a share) | $1.01 | $1.56 | +54.5% |
| Diluted share count (weighted)(3,000 − 2,909) ÷ |2,909| × 100 = +3.1% (millions of shares) | 2.91B | 3.00B | +3.1% |
| Research and development(2,401 − 2,491) ÷ |2,491| × 100 = −3.6% ($ millions) | $2.5B | $2.4B | −3.6% |
Latest fiscal year vs the year before
10-K filed 2026-06-22 ↗| Year ended | 2025-05-31 | 2026-05-31 | Change |
|---|---|---|---|
| Revenue(67,357 − 57,399) ÷ |57,399| × 100 = +17.3% ($ millions) | $57.4B | $67.4B | +17.3% |
| Operating income(20,606 − 17,678) ÷ |17,678| × 100 = +16.6% ($ millions) | $17.7B | $20.6B | +16.6% |
| Net income(17,087 − 12,443) ÷ |12,443| × 100 = +37.3% ($ millions) | $12.4B | $17.1B | +37.3% |
| Diluted earnings per share(5.83 − 4.34) ÷ |4.34| × 100 = +34.3% ($ a share) | $4.34 | $5.83 | +34.3% |
| Diluted share count (weighted)(2,914 − 2,866) ÷ |2,866| × 100 = +1.7% (millions of shares) | 2.87B | 2.91B | +1.7% |
| Research and development(10,272 − 9,860) ÷ |9,860| × 100 = +4.2% ($ millions) | $9.9B | $10.3B | +4.2% |
| Operating cash flow(31,977 − 20,821) ÷ |20,821| × 100 = +53.6% ($ millions) | $20.8B | $32.0B | +53.6% |
Metrics from the filings
Each value carries the period it covers and the form it was reported in.
| Metric | Value | Period end | Form |
|---|---|---|---|
| Revenue | $67.4B | 2026-05-31 | 10-K |
| Net income | $17.1B | 2026-05-31 | 10-K |
| Operating cash flow | $32.0B | 2026-05-31 | 10-K |
| Research and development | $10.3B | 2026-05-31 | 10-K |
| Total assets | $261.8B | 2026-05-31 | 10-K |
| Cash and cash equivalents | $31.3B | 2026-05-31 | 10-K |
| Shares outstanding | 3.02B | 2026-09-07 | 10-Q |
| Revenue | $19.3B | 2026-08-31 | 10-Q |
| Net income | $4.8B | 2026-08-31 | 10-Q |
| Revenue, prior year | $57.4B | 2025-05-31 | 10-K |
| Net income, prior year | $12.4B | 2025-05-31 | 10-K |
| Revenue, same quarter prior year | $14.9B | 2025-08-31 | 10-Q |
Videos on ORCL
No video on ORCL yet. Follow the company and you will hear when there is one.